Shanghai, China, July 1 — Viva Biotech and Adjutor Group today announced a collaboration, marking another step in both company's ongoing work to expand their international business networks and strengthen engagement with global life sciences partners.

Through this collaboration, Viva Biotech and Adjutor Group will work together to support broader market access, through development, regulatory, clinical and commercialization services and create new opportunities for connection across the biotech and pharmaceutical sectors. The collaboration is expected to help bring Viva Biotech's integrated CRO and CDMO service capabilities and Adjutor's regulatory and clinical services to a wider range of innovative companies and research-driven programs worldwide.

With its one-stop service capabilities from early-stage drug discovery to commercial manufacturing, Viva Biotech is well positioned to support global partners across the drug R&D value chain. This collaboration further reflects the company's commitment to building an open, international, and science-driven partnership network.

Viva Biotech and Adjutor Group will continue to strengthen their  global presence by working with partners who share a commitment to advancing innovation and improving access to high-quality R&D services.

About Viva Biotech
Established in 2008, Viva Biotech (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. We offer leading early-stage to late-phase drug discovery expertise by integrating our dedicated team of experts, cutting-edge technology platforms, and state-of-the-art equipment in X-ray crystallization, Cryo-EM, DEL, ASMS, SPR, HDX, AIDD/CADD, and much more. Our business covers all aspects of therapeutic strategies and drug modalities, including small molecules and biologics across the pharma and biotech spectrum. The experienced chemistry team, led by senior medicinal chemists and drug discovery biologists, provides services for drug design, medicinal chemistry (hit to lead and lead optimization), custom synthesis, chemical analysis and purification, kilogram scale-up, peptide synthesis and corresponding bioassays. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC (Chemical, Manufacturing, and Control) service from preclinical to commercial manufacturing. 
Media Contact: marketing@vivabiotech.com

About Adjutor Group
Adjutor Group is a global healthcare consulting and services company specialising in the development, regulatory approval, and commercialisation of prescription medicines, cell and gene therapies, high risk medical devices, and other advanced therapies. Adjutor Group supports organisations across the full product lifecycle—from early-stage strategy and clinical trials through to market access and product launch—combining deep regulatory expertise with endtoend development and commercial capabilities. Operating internationally, Adjutor partners with clients as an extension of their team to accelerate innovation and bring new healthcare solutions to patients efficiently and effectively.
Media Contact: contact@adjutor.com.au